dalteparin has been researched along with creatine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busby, LT; Rodgers, GM; Weyman, A | 1 |
| Andreux, JP; Bellot, O; Gouin, I; Pautas, E; Siguret, V | 1 |
| Deepa, PR; Varalakshmi, P | 1 |
1 trial(s) available for dalteparin and creatine
| Article | Year |
|---|---|
Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Antithrombin III; Atrial Fibrillation; Body Weight; Creatine; Drug Interactions; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Platelet Count; Renal Insufficiency; Tinzaparin; Venous Thrombosis | 2002 |
2 other study(ies) available for dalteparin and creatine
| Article | Year |
|---|---|
Excessive anticoagulation in patients with mild renal insufficiency receiving long-term therapeutic enoxaparin.
Topics: Adult; Anticoagulants; Creatine; Drug Monitoring; Enoxaparin; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Renal Insufficiency; Thrombosis | 2001 |
Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis.
Topics: Albinism; Alkaline Phosphatase; Animals; Arteriosclerosis; Cholesterol; Creatine; Creatine Kinase; Diet, Atherogenic; Heart; Heparin, Low-Molecular-Weight; Kidney; L-Lactate Dehydrogenase; Liver; Male; Rats; Rats, Wistar; Serum Albumin; Transaminases; Urea; Uric Acid | 2004 |